Korean traditional Chungkookjang improves body composition, lipid profiles and atherogenic indices in overweight/obese subjects: a double-blind, randomized, crossover, placebo-controlled clinical trial

被引:39
|
作者
Byun, M-S [1 ,2 ]
Yu, O-K [1 ]
Cha, Y-S [1 ,2 ]
Park, T-S [1 ,3 ]
机构
[1] Chonbuk Natl Univ, Dept Obes Res Ctr, Jeonju, South Korea
[2] Chonbuk Natl Univ, Dept Food Sci & Human Nutr, 664-14 Duckjin Dong, Jeonju 561756, Jeonbuk, South Korea
[3] Chonbuk Natl Univ, Dept Internal Med, Div Endocrinol & Metab, Sch Med, Jeonju, South Korea
关键词
SOY-PROTEIN; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN-B; OBESE SUBJECTS; RISK MARKERS; WEIGHT-LOSS; CHOLESTEROL; ATHEROSCLEROSIS; SUPPLEMENTATION; DYSLIPIDEMIA;
D O I
10.1038/ejcn.2016.77
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
BACKGROUND/OBJECTIVES: Chungkookjang is a Korean representative fermented soybean food. In this study, we investigated the effect of Korean traditional Chungkookjang compared with placebo on body composition, dyslipidemia and risk factors for atherosclerosis in overweight/obese subjects. SUBJECTS/METHODS: This double-blind, randomized, controlled crossover trial was conducted on 120 overweight/obese subjects, aged 19-29 years. Subjects were randomly divided into a Chungkookjang (n = 60) or a placebo (n = 60) group. After 12 weeks, the groups were crossed over for an additional 12 weeks. During the intervention period, subjects were asked to maintain their usual diet and activity and not to take any functional foods or dietary supplements. The anthropometric measures, lipid profiles and atherogenic indices were determined at baseline and at the end of each 12-week period. RESULTS: The anthropometry measurements, percentage body fat, lean body mass, waist circumference and waist-to-hip ratio of women in the Chungkookjang group were significantly improved compared with the placebo group. Lipid profiles and high-sensitivity C-reactive protein of women in Chungkookjang were significantly improved. The atherogenic indices of apolipoprotein B/apolipoprotein A1 decreased in both the placebo and the Chungkookjang group, and it also decreased below 0.55 for all the men and women in the Chungkookjang group. CONCLUSIONS: In conclusion, these results suggest that supplementation with Chungkookjang may improve body composition and risk factors for cardiovascular disease in overweight and obese adults.
引用
收藏
页码:1116 / 1122
页数:7
相关论文
共 50 条
  • [31] Ketone monoester ingestion improves cardiac function in adults with type 2 diabetes: a double-blind, placebo-controlled, randomized, crossover trial
    Perissiou, M.
    Saynor, Z. L.
    Feka, K.
    Edwards, C.
    James, T. J.
    Corbett, J.
    Mayes, H.
    Shute, J.
    Cummings, M.
    Black, M. I.
    Strain, W. D.
    Little, J. P.
    Shepherd, A. I.
    JOURNAL OF APPLIED PHYSIOLOGY, 2025, 138 (02) : 546 - 558
  • [32] Dietary blueberry improves cognition among older adults in a randomized, double-blind, placebo-controlled trial
    Miller, Marshall G.
    Hamilton, Derek A.
    Joseph, James A.
    Shukitt-Hale, Barbara
    EUROPEAN JOURNAL OF NUTRITION, 2018, 57 (03) : 1169 - 1180
  • [33] Zinc monotherapy increases serum brainderived neurotrophic factor (BDNF) levels and decreases depressive symptoms in overweight or obese subjects: A double-blind, randomized, placebo-controlled trial
    Solati, Zahra
    Jazayeri, Shima
    Tehrani-Doost, Mehdi
    Mahmoodianfard, Salma
    Gohari, Mahmood Reza
    NUTRITIONAL NEUROSCIENCE, 2015, 18 (04) : 162 - 168
  • [34] Oxytocin Administration Increases Proactive Control in Men with Overweight or Obesity: A Randomized, Double-Blind, Placebo-Controlled Crossover Study
    Plessow, Franziska
    Marengi, Dean A.
    Perry, Sylvia K.
    Lawson, Elizabeth A.
    OBESITY, 2021, 29 (01) : 56 - 61
  • [35] Melatonin in Assisted Reproductive Technology: A Pilot Double-Blind Randomized Placebo-Controlled Clinical Trial
    Fernando, Shavi
    Wallace, Euan Morrison
    Vollenhoven, Beverley
    Lolatgis, Nicholas
    Hope, Nicole
    Wong, Melissa
    Lawrence, Mark
    Lawrence, Anthony
    Russell, Chris
    Leong, Kenneth
    Thomas, Philip
    Rombauts, Luk
    FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [36] Resveratrol reduces albuminuria in diabetic nephropathy: A randomized double-blind placebo-controlled clinical trial
    Sattarinezhad, A.
    Roozbeh, J.
    Yeganeh, B. Shirazi
    Omrani, G. R.
    Shams, M.
    DIABETES & METABOLISM, 2019, 45 (01) : 53 - 59
  • [37] Resveratrol Does Not Influence Metabolic Risk Markers Related to Cardiovascular Health in Overweight and Slightly Obese Subjects: A Randomized, Placebo-Controlled Crossover Trial
    van der Made, Sanne M.
    Plat, Jogchum
    Mensink, Ronald P.
    PLOS ONE, 2015, 10 (03):
  • [38] Role of Folic Acid in Atherosclerosis After Kidney Transplant: A Double-blind, Randomized, Placebo-controlled Clinical Trial
    Nafar, Mohsen
    Khatami, Fatemeh
    Kardavani, Babak
    Farjad, Reza
    Pour-Reza-Gholi, Fatemeh
    Firouzan, Ahmad
    Kalantar, Akbar
    Farhangi, Soudabeh
    Einollahi, Behzad
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2009, 7 (01) : 33 - 39
  • [39] Treatment with rhubarb improves brachial artery endothelial function in patients with atherosclerosis: A randomized, double-blind, placebo-controlled clinical trial
    Liu, Yun-Fang
    Yu, Hui-Ming
    Zhang, Cheng
    Yan, Fang-Fang
    Liu, Yan
    Zhang, Yun
    Zhang, Mei
    Zhao, Yu-Xia
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2007, 35 (04): : 583 - 595
  • [40] Effect of calcium supplementation on lipid profile in overweight or obese Iranian women: a double-blind randomized clinical trial
    M Karandish
    S Shockravi
    M T Jalali
    M H Haghighizadeh
    European Journal of Clinical Nutrition, 2009, 63 : 268 - 272